Owkin Announces First-ever Large-scale Use of AI to Enhance Clinical Trials

A French-American healthcare unicorn Owkin, which applies artificial intelligence (AI) and federated learning frameworks to drug discovery, has just announced …

Continue ›››

The First Innovation in Treatment of Low Testosterone in Men Since 1930th

Acesis Biomed, a biotechnology company based in the US and the UK, is developing an innovative solution for the treatment …

Continue ›››

Insilico Medicine Snaps Up $60M to Create Robotic Lab of the Future

Hong Kong-based pioneer of the artificial intelligence (AI)-driven drug discovery, a clinical stage biotech Insilico Medicine, has completed a $60 …

Continue ›››

Professor Sidney Altman

Because of the war I’ve missed the news about the death of Sidney Altman on April 5, 2022. Altman is …

Continue ›››

Tissue Selective E3 Ligase-based Degraders

The efficacy and selectivity of protein degrader drugs depend on their affinity to the target protein but also on the type …

Continue ›››

Virtual Reality in Drug Discovery: More Useful Than You Probably Think

Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …

Continue ›››

Bioengineered Extracellular Vesicles - Potential Boon for Delivering Biotherapeutics

Because of endogenous properties, extracellular vesicles (EVs) have shown impressive potential as remedial modalities; nevertheless, more bioengineering refinement is expected …

Continue ›››

Gearing AI to Fight Pandemics: a Novel COVID-19 Drug Candidate Announced

Hong Kong-based clinical stage drug discovery company Insilico Medicine just announced the nomination of a novel preclinical drug candidate for …

Continue ›››

Quarterbacking a Patient's Fight Against Cancer

In the incredibly competitive world of drug development, comprehensive precision, and healthtech, every strategic control point is essential. Over the …

Continue ›››

Oligonucleotide Therapeutics and Delivery Conference 2022

Date: 21st – 22nd September 2022 Location: London, UK Website: http://www.oligonucleotide.co.uk/BioPharmaTrend Read more ›››

The Promise of Next-Generation Proteomics in Revolutionizing Cancer Research and Treatment

Artificial intelligence (AI) is undoubtedly a big deal in the pharmaceutical industry, bringing the unprecedented abilities of modeling biology at …

Continue ›››

Meet the Company Using Artificial Intelligence for Designing Targeted Protein Degraders

Proteins are essential components of living matter – they function as building blocks for cells and tissues, as well as …

Continue ›››